Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7P37 is a processed pseudogene corresponding to the ribosomal protein L7 gene; it does not encode a functional protein. Like other ribosomal protein pseudogenes, it is a non-functional, duplicated genetic element found dispersed in the human genome and is not known to have any biological function, role in disease, or value as a therapeutic target. RPL7P37 is distinct from the functional ribosomal protein L7 gene (RPL7), which participates in ribosome assembly and protein synthesis. The designation "pseudogene" indicates that RPL7P37 cannot produce a functional protein and cannot be considered a therapeutic target. Pseudogenes typically arise via retrotransposition or genomic duplication and do not have significant biological roles. The functional counterpart, ribosomal protein L7 (RPL7), is an essential component of the 60S ribosomal subunit, but RPL7P37 is not active in translation or associated cellular processes. There are no known drugs, mechanisms, biomarkers, or roles in disease for this pseudogene, and the listing as a therapeutic target would be inappropriate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 37 (RPL7P37).